SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹14,072 Cr | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr | ₹6,170 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹14,072 Cr |
| Mar2024 | ₹12,135 Cr |
| Mar2023 | ₹4,959 Cr |
| Mar2022 | ₹8,985 Cr |
| Mar2021 | ₹6,170 Cr |
How is Cash Flow from Operating Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,072 Cr | 15.96 | |
| Mar2024 | ₹12,135 Cr | 144.69 | |
| Mar2023 | ₹4,959 Cr | -44.80 | |
| Mar2022 | ₹8,985 Cr | 45.61 | |
| Mar2021 | ₹6,170 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,425.1 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
| MANKIND PHARMA | ₹85,050.2 Cr | -1.1% | -8.2% | -17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% |
-0.1% |
-2% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses